Literature DB >> 8175899

Recombinant GST-human osteopontin fusion protein is functional in RGD-dependent cell adhesion.

J W Xuan1, C Hota, A F Chambers.   

Abstract

Osteopontin (OPN) is a secreted phosphoprotein expressed by many tumor cells, as well as a limited set of normal cells. Native OPN has been shown to support cell adhesion in an RGD-peptide-inhibitable fashion. Here we expressed human OPN in E. coli as a recombinant fusion protein with glutathione-S-transferase (GST). We report that the GST-OPN fusion protein has functional activity. PAP2 (ras-transformed, metastatic murine NIH 3T3) and MDA-MB-435 human mammary carcinoma cells bound to GST-OPN in an in vitro cell adhesion assay nearly as well as to native bovine OPN. Adhesion to the recombinant fusion protein was blocked by addition of GRGDS peptide, suggesting that the cells adhere to the recombinant and native OPN proteins by similar, integrin-mediated mechanisms. Adhesion to both sources of OPN also was inhibited by thrombin treatment of the protein. Thrombin cleaves GST from OPN in the fusion protein, and also cleaves internally in OPN, adjacent to the RGD sequence of the protein. Our results suggest that (a) thrombin cleavage of native OPN may be a natural regulator of OPN function, and (b) the majority of OPN cell binding activity is mediated by the RGD sequence in the protein backbone, with little or no requirement for post-translational modifications that occur in native OPN for adhesive function as measured here.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8175899     DOI: 10.1002/jcb.240540213

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  16 in total

1.  Pre- and post-translational regulation of osteopontin in cancer.

Authors:  Pieter H Anborgh; Jennifer C Mutrie; Alan B Tuck; Ann F Chambers
Journal:  J Cell Commun Signal       Date:  2011-04-26       Impact factor: 5.782

2.  Role of the integrin-binding protein osteopontin in lymphatic metastasis of breast cancer.

Authors:  Alison L Allan; Rosamma George; Sharon A Vantyghem; Mark W Lee; Nicole C Hodgson; C Jay Engel; Ron L Holliday; David P Girvan; Leslie A Scott; Carl O Postenka; Waleed Al-Katib; Larry W Stitt; Toshimitsu Uede; Ann F Chambers; Alan B Tuck
Journal:  Am J Pathol       Date:  2006-07       Impact factor: 4.307

Review 3.  CD44 and the adhesion of neoplastic cells.

Authors:  Z Rudzki; S Jothy
Journal:  Mol Pathol       Date:  1997-04

Review 4.  Bone sialoprotein and osteopontin in bone metastasis of osteotropic cancers.

Authors:  Thomas E Kruger; Andrew H Miller; Andrew K Godwin; Jinxi Wang
Journal:  Crit Rev Oncol Hematol       Date:  2013-09-07       Impact factor: 6.312

5.  Cellular mechanisms mediating the anti-invasive properties of the ornithine decarboxylase inhibitor alpha-difluoromethylornithine (DFMO) in human breast cancer cells.

Authors:  Andrea Manni; Sharlene Washington; David Mauger; Deborah A Hackett; Michael F Verderame
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

Review 6.  The role of osteopontin in breast cancer: clinical and experimental studies.

Authors:  A B Tuck; A F Chambers
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-10       Impact factor: 2.673

7.  Extracellular and intracellular mechanisms that mediate the metastatic activity of exogenous osteopontin.

Authors:  Jami Mandelin; Emme C K Lin; Dana D Hu; Susan K Knowles; Kim-Anh Do; Xuemei Wang; E Helene Sage; Jeffrey W Smith; Wadih Arap; Renata Pasqualini
Journal:  Cancer       Date:  2009-04-15       Impact factor: 6.860

8.  Posttranslational modifications of bovine osteopontin: identification of twenty-eight phosphorylation and three O-glycosylation sites.

Authors:  E S Sørensen; P Højrup; T E Petersen
Journal:  Protein Sci       Date:  1995-10       Impact factor: 6.725

9.  Effect of osteopontin alleles on beta-glucan-induced granuloma formation in the mouse liver.

Authors:  Kumiko Tanaka; Junko Morimoto; Shigeyuki Kon; Chiemi Kimura; Manabu Inobe; Hongyan Diao; Gregor Hirschfeld; Johannes M Weiss; Toshimitsu Uede
Journal:  Am J Pathol       Date:  2004-02       Impact factor: 4.307

10.  The role of osteopontin in inflammatory processes.

Authors:  Susan Amanda Lund; Cecilia M Giachelli; Marta Scatena
Journal:  J Cell Commun Signal       Date:  2009-10-02       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.